Bayer CEO: targeting US state regulation to stem glyphosate costs
BERLIN, April 17 (Reuters) - Bayer BAYGn.DE hopes to stem the costs of litigation over its weedkiller glyphosate by lobbying U.S. states to adjust their regulatory framework, the German chemicals company's CEO said in a draft speech released on Thursday.
"We are working towards this with lawmakers and gaining support beyond party lines," Chief Executive Bill Anderson said in a transcript of his speech for the company's annual shareholders' meeting on April 25.
Anderson said there was a risk that litigation could force Bayer to stop marketing glyphosate, adding: "We don't want that, but we have to prepare ourselves for all possible developments."
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

Gold Price Forecast: U.S.-Iran Tensions Ease, Nonfarm Payrolls Looming, What’s Next for Gold?

SpaceX IPO Approaches: Musk Dissolves xAI into SpaceX and Subleases 300MW Compute to Anthropic; Can the $2 Trillion Valuation Hold?

Why SanDisk Stock Could Soar to $4,000?

Tradingkey







